.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 7,994,351

« Back to Dashboard

Details for Patent: 7,994,351

Title:Preparation of bile acids and intermediates thereof
Abstract: Synthetic methods for preparing deoxycholic acid and intermediates thereof are provided.
Inventor(s): Prasad; Achampeta Rathan (Hyderabad, IN), Swaringen, Jr.; Roy A. (Durham, NC), Reid; John Gregory (Niskayuma, NY), Moriarty; Robert M. (Michiana Shores, IN), Sahoo; Akhila Kumar (Bhubaneswar, IN)
Assignee: Kythera Biopharmaceuticals, Inc. (Calabasas, CA)
Filing Date:Nov 06, 2009
Application Number:12/613,969
Claims:1. A compound selected from the group consisting of 9.alpha.-hydroxy-5.beta.-androstan-3,17-dione (1.1); 5.beta.-androst-9(11)-en-3,17-dione (1.2); (Z)-3.alpha.-hydroxy-5.beta.-pregna-9(11),17(20)-diene (1.5); (Z)-3.alpha.-acetoxy-5.beta.-pregna-9(11),17(20)-diene (1.6); (E)-methyl 3.alpha.-acetoxy-5.beta.-chol-9(11), 16, 22-trien-24-oate (1.7a); and methyl 3.alpha.-acetoxy-5.beta.-chol-9(11), 16-dien-24-oate (1.7b).

2. The compound of claim 1, which is 9.alpha.-hydroxy-5.beta.-androstan-3,17-dione (1.1).

3. The compound of claim 1, which is 5.beta.-androst-9(11)-en-3,17-dione (1.2).

4. The compound of claim 1, which is (Z)-3.alpha.-hydroxy-5.beta.-pregna-9(11),17(20)-diene (1.5).

5. The compound of claim 1, which is (Z)-3.alpha.-acetoxy-5.beta.-pregna-9(11),17(20)-diene (1.6).

6. The compound of claim 1, which is (E)-methyl 3.alpha.-acetoxy-5.beta.-chol-9(11), 16,22-trien-24-oate (1.7a).

7. The compound of claim 1, which is methyl 3.alpha.-acetoxy-5.beta.-chol-9(11), 16-dien-24-oate (1.7b).

8. A method of preparing a compound of formula 1.9: ##STR00029## said method comprising: (a) reacting 9.alpha.-hydroxyandrost-4-en-3,17-dione 1.0 with H.sub.2 under hydrogenation conditions to form compound 1.1 ##STR00030## (b) reacting compound 1.1 with acid to form compound 1.2 ##STR00031## (c) reacting compound 1.2 with a reducing agent to form compound 1.3 or a mixture of 1.3 and 1.4 ##STR00032## (d) reacting compound 1.3 with a two carbon olefination reagent under olefin forming conditions to form compound 1.5 ##STR00033## (e) converting compound 1.5 to a compound of formula 1.6 wherein P is a protecting group ##STR00034## (f) reacting the compound of formula 1.6 with an alkylpropiolate of the formula CH.ident.CC(O)OR or an alkyl acrylate of the formula CH.sub.2.dbd.CHC(O)OR, wherein R is alkyl, in the presence of a Lewis acid to form a compound of formula 1.7 wherein P is a protecting group, R is an alkyl, and the dashed line is a single or double bond; ##STR00035## (g) reacting the compound of formula 1.7 with H.sub.2 under hydrogenation conditions to form a compound of formula 1.8 wherein P is a protecting group and R is alkyl ##STR00036## (h) reacting the compound of formula 1.8 with an oxidizing agent to form the compound of formula 1.9 wherein P is a protecting group and R is alkyl.

9. A method for preparing deoxycholic acid (DCA) or a pharmaceutically acceptable salt thereof: ##STR00037## said method comprising (a) reacting 9.alpha.-hydroxyandrost-4-en-3,17-dione 1.0 with H.sub.2 under hydrogenation conditions comprising a Pd/C catalyst to form compound 1.1 ##STR00038## (b) reacting compound 1.1 with H.sub.2SO.sub.4 to form compound 1.2 ##STR00039## (c) reacting compound 1.2 with LiAl(OtBu).sub.3H to form compound 1.3 or a mixture of 1.3 and 1.4 ##STR00040## (d) reacting compound 1.3 with Ph.sub.3PCH.sub.2CH.sub.3.sup.+Br under olefin forming conditions to form compound 1.5 ##STR00041## (e) converting compound 1.5 to a compound of formula 1.6 ##STR00042## (f) reacting the compound of formula 1.6 with methylpropiolate of the formula CH.ident.CC(O)OCH.sub.3 or methyl acrylate of the formula CH.sub.2.dbd.CHC(O)OCH.sub.3, in the presence of EtAlCl.sub.2 to form a compound of formula 1.7 wherein, and the dashed line is a single or double bond; ##STR00043## (g) reacting the compound of formula 1.7 with H.sub.2 under hydrogenation conditions comprising a PtO.sub.2 catalyst to form a compound of formula 1.8 ##STR00044## (h) reacting the compound of formula 1.8 with CrO.sub.3 to form a compound of formula 1.9 ##STR00045## (i) reacting the compound of formula 1.9 with H.sub.2 under hydrogenation conditions comprising a Pd/C catalyst to form a compound of formula 2.0 ##STR00046## (j) reacting the compound of formula 2.0 with LiAl(OtBu).sub.3H to form a compound of formula 2.1 ##STR00047## (k) exposing the compound of formula 2.1 to deprotection and hydrolysis conditions comprising LiOH to form deoxycholic acid or a pharmaceutically acceptable salt thereof.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc